Rituximab Maintenance After Autologous Transplantation

Clinical trial NCT01103388 · TERMINATED

Trial details

NCT number: NCT01103388
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma

Start date: 2003-08-01
Primary completion: 2006-04-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.